Jade Biosciences, Inc.JBIO stock score: 36/100

$15.06 · -2.78% · Scored Nov 19, 2026

Technical
38
Fundamental
36
News
49

The reading

Jade Biosciences (JBIO) scores 36 out of 100, which reads bearish, higher than 14% of Healthcare stocks and 15% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 36, technicals 38.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Quality (Yearly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 42 and contrarian oscillators 50.

News sentiment is neutral at 49; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 30 to 45, and it is down 7 points over the period.

About Jade Biosciences

Jade Biosciences (JBIO) is a clinical-stage biotechnology company developing antibody therapies for autoimmune and inflammatory diseases. Its lead candidate is an antibody that targets APRIL, a protein that drives production of immunoglobulin A, and is being developed for IgA nephropathy, a chronic kidney disease in which abnormal IgA deposits damage the kidneys. Early data in healthy volunteers showed deep, lasting IgA reductions after a single dose, and the drug has moved into a mid-stage trial in patients. The pipeline also includes an antibody against the BAFF receptor intended for autoimmune diseases such as rheumatoid arthritis, along with an earlier program. The company has no product revenue and funds its research with cash raised from investors.

In IgA nephropathy, Jade faces competition from Otsuka, Vera Therapeutics, Vertex and Novartis, which have approved or late-stage drugs for the disease, along with established kidney treatments. Its edge rests on an antibody engineered for a long half-life, which could allow dosing every few months, and on a focused pipeline aimed at immune targets with validated biology. Investors who follow JBIO stock tend to watch data from the mid-stage IgA nephropathy trial and plans for a pivotal study. Early trials of its other candidates are closely followed. Cash runway, competitors’ clinical and regulatory progress, and any partnership deals are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward JBIO’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

36

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • How reliably yearly earnings grow: the share of years with higher earnings, the compound growth rate, how steady that growth is, and the last two yearly changes.

  • Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.

  • Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.

26 weighted scorers; 13 had no data today and are left out rather than counted as zero.

Technical · daily

41

Pulling it up

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • Know Sure Thing (KST) combines multiple rate-of-change calculations to identify long-term trend reversals.

  • Where the close sits against its 50-day SMA.

Holding it back

  • Where the close sits against its 100-day SMA.

  • Where the close sits against its 200-day SMA.

  • Simple Moving Average (100-period) provides a longer-term perspective on price trends.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
49

Technical score by timeframe

ChartScoreWeight
Hourly371
Daily413
Weekly272
Monthly452

Composite score, last 90 days

05010036Aug 22, 2026Nov 19, 2026Aug 22, 2026: 43Aug 23, 2026: 43Aug 24, 2026: 43Aug 25, 2026: 45Aug 26, 2026: 43Aug 27, 2026: 42Aug 28, 2026: 41Aug 29, 2026: 42Aug 30, 2026: 41Aug 31, 2026: 43Sep 1, 2026: 42Sep 2, 2026: 45Sep 3, 2026: 40Sep 4, 2026: 39Sep 5, 2026: 40Sep 6, 2026: 40Sep 7, 2026: 40Sep 8, 2026: 40Sep 9, 2026: 39Sep 10, 2026: 38Sep 11, 2026: 37Sep 12, 2026: 37Sep 13, 2026: 37Sep 14, 2026: 37Sep 15, 2026: 34Sep 16, 2026: 34Sep 17, 2026: 36Sep 18, 2026: 36Sep 19, 2026: 35Sep 20, 2026: 35Sep 21, 2026: 36Sep 22, 2026: 36Sep 23, 2026: 35Sep 24, 2026: 35Sep 25, 2026: 34Sep 26, 2026: 34Sep 27, 2026: 34Sep 28, 2026: 34Sep 29, 2026: 34Sep 30, 2026: 34Oct 1, 2026: 34Oct 2, 2026: 36Oct 3, 2026: 35Oct 4, 2026: 35Oct 5, 2026: 36Oct 6, 2026: 34Oct 7, 2026: 34Oct 8, 2026: 36Oct 9, 2026: 37Oct 10, 2026: 37Oct 11, 2026: 37Oct 12, 2026: 36Oct 13, 2026: 34Oct 14, 2026: 34Oct 15, 2026: 34Oct 16, 2026: 35Oct 17, 2026: 34Oct 18, 2026: 34Oct 19, 2026: 35Oct 20, 2026: 37Oct 21, 2026: 39Oct 22, 2026: 38Oct 23, 2026: 35Oct 24, 2026: 36Oct 25, 2026: 37Oct 26, 2026: 35Oct 27, 2026: 38Oct 28, 2026: 36Oct 29, 2026: 37Oct 30, 2026: 35Nov 1, 2026: 36Nov 2, 2026: 36Nov 3, 2026: 38Nov 4, 2026: 39Nov 5, 2026: 36Nov 6, 2026: 38Nov 7, 2026: 36Nov 8, 2026: 36Nov 10, 2026: 41Nov 11, 2026: 41Nov 12, 2026: 30Nov 13, 2026: 32Nov 14, 2026: 38Nov 15, 2026: 38Nov 16, 2026: 37Nov 17, 2026: 37Nov 18, 2026: 37Nov 19, 2026: 36
Show the daily numbers
DateComposite
Nov 19, 202636
Nov 18, 202637
Nov 17, 202637
Nov 16, 202637
Nov 15, 202638
Nov 14, 202638
Nov 13, 202632
Nov 12, 202630
Nov 11, 202641
Nov 10, 202641
Nov 8, 202636
Nov 7, 202636
Nov 6, 202638
Nov 5, 202636
Nov 4, 202639
Nov 3, 202638
Nov 2, 202636
Nov 1, 202636
Oct 30, 202635
Oct 29, 202637
Oct 28, 202636
Oct 27, 202638
Oct 26, 202635
Oct 25, 202637
Oct 24, 202636
Oct 23, 202635
Oct 22, 202638
Oct 21, 202639
Oct 20, 202637
Oct 19, 202635
Oct 18, 202634
Oct 17, 202634
Oct 16, 202635
Oct 15, 202634
Oct 14, 202634
Oct 13, 202634
Oct 12, 202636
Oct 11, 202637
Oct 10, 202637
Oct 9, 202637
Oct 8, 202636
Oct 7, 202634
Oct 6, 202634
Oct 5, 202636
Oct 4, 202635
Oct 3, 202635
Oct 2, 202636
Oct 1, 202634
Sep 30, 202634
Sep 29, 202634
Sep 28, 202634
Sep 27, 202634
Sep 26, 202634
Sep 25, 202634
Sep 24, 202635
Sep 23, 202635
Sep 22, 202636
Sep 21, 202636
Sep 20, 202635
Sep 19, 202635
Sep 18, 202636
Sep 17, 202636
Sep 16, 202634
Sep 15, 202634
Sep 14, 202637
Sep 13, 202637
Sep 12, 202637
Sep 11, 202637
Sep 10, 202638
Sep 9, 202639
Sep 8, 202640
Sep 7, 202640
Sep 6, 202640
Sep 5, 202640
Sep 4, 202639
Sep 3, 202640
Sep 2, 202645
Sep 1, 202642
Aug 31, 202643
Aug 30, 202641
Aug 29, 202642
Aug 28, 202641
Aug 27, 202642
Aug 26, 202643
Aug 25, 202645
Aug 24, 202643
Aug 23, 202643
Aug 22, 202643

Key facts

Market cap
$1.0B
Sector
Healthcare
Industry
Biotechnology
Beta
—
Risk grade (1–10)
9
Next earnings
Nov 13, 2026

Questions

What is JBIO's stock rating today?

JBIO scores 36/100 (Bearish) as of Nov 19, 2026: technical 38, fundamental 36, and news sentiment 49, which is shown but not counted. Scores are recomputed every night.

What does Jade Biosciences do?

Jade Biosciences (JBIO) is a clinical-stage biotechnology company developing antibody therapies for autoimmune and inflammatory diseases. Its lead candidate is an antibody that targets APRIL, a protein that drives production of immunoglobulin A, and is being developed for IgA nephropathy, a chronic kidney disease in which abnormal IgA deposits damage the kidneys.

Is JBIO stock a buy?

The score is not a buy or sell recommendation. A 36 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the JBIO score calculated?

88 weighted scorers feed it today: 26 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

JBIO stock score

HTML

<a href="https://stocksscores.com/stocks/jbio/"><img src="https://stocksscores.com/stocks/jbio/badge.svg" alt="JBIO stock score" height="20"></a>

Markdown

[![JBIO stock score](https://stocksscores.com/stocks/jbio/badge.svg)](https://stocksscores.com/stocks/jbio/)